首页> 外文期刊>ACS medicinal chemistry letters >Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists
【24h】

Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists

机译:脑渗透性P2X7受体拮抗剂的合成,SAR和药理学表征

获取原文
获取原文并翻译 | 示例
           

摘要

We describe the synthesis and SAR of 1,2,3-triazolopiperidines as a novel series of potent, brain penetrant P2X7 antagonists. Initial efforts yielded a series of potent human P2X7R antagonists with moderate to weak rodent potency, some CYP inhibition, poor metabolic stability, and low solubility. Further work in this series, which focused on the SAR of the N-linked heterocyde, not only increased the potency at the human P2X7R but also provided compounds with good potency at the rat P2X7R These efforts eventually delivered a potent rat and human P2X7R antagonist with good physicochemical properties, an excellent pharmacokinetic profile, good partitioning into the CNS, and demonstrated in vivo target engagement after oral dosing.
机译:我们将1,2,3-三唑并哌啶类化合物的合成和SAR描述为一种新型的,有效的脑渗透剂P2X7拮抗剂。最初的努力产生了一系列有效的人P2X7R拮抗剂,它们具有中等至弱的啮齿动物效力,某些CYP抑制作用,不良的代谢稳定性和低溶解度。该系列的进一步工作侧重于N-连接的杂环的SAR,不仅增加了对人P2X7R的效价,而且还为对大鼠P2X7R的效价提供了良好的化合物。良好的理化特性,出色的药代动力学特征,良好的分配到中枢神经系统的能力,并在口服给药后证明了体内靶标的参与。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号